Current Month 2010
Article Features
  Asthma Drug May Prevent Spread of Breast Cancer
Breast Cancer Patients Prefer Silicone over Saline Implants After Mastectomy
Breast Cancer Survivors Often Rate Post-Treatment Breast Appearance Only "Fair"
Chemoprevention Biomarker for Breast Cancer Identified
Combined Imaging Technologies May Better Identify Cancerous Breast Lesions
Coping with Cancer is Worse for Young Adults In Spite of Better Survival Odds
Cough Medicine Could Help Doctors Identify How Breast Cancer Patients Metabolize Tamoxifen
Erythropoietin Counteracts Breast Cancer Treatment with Herceptin
Genetic Variants May Affect the Risk of Breast Cancer in Women with BRCA2 Mutations
Joint Pain Linked to Breast Cancer Drug, Not Inflammatory Arthritis or Autoimmune Disease
New Risk Factor for Developing Breast Cancer
Obesity Not Linked to Breast Cancer in Mexican-American Women
PARP Inhibitor, MK-4827, Shows Anti-Tumor Activity in First Trial in Humans
Patient Navigations Improve Mammography Rates in Minority Women
Personalized Medicine: Tumor Analysis Reveals New Opportunities for Existing Cancer Drugs
Pit-1 Expression May Help Predict Outcomes in Breast Cancer
Radiation Fears Should Not Deter Women from Mammography Screening
Research Rejects Green Tea for Breast Cancer Prevention
Researchers Identify Key Enzyme That Regulates the Early Growth of Breast Cancer Cells
Scientists Identify New Mechanism Regulating Daily Biological Rhythms
Scientists Identify Potential New Target for Treating Triple Negative Breast Cancer
Side Effects of Hormonal Breast Cancer Therapy Increased, May Affect Treatment Adherence
Smoking Increased Risk of Death in Women with Breast Cancer
Soy Isoflavones May Modify Risk of Breast Cancer
Study Sheds Light on Aromatase Inhibitor Joint Pain Syndrome


Side Effects of Hormonal Breast Cancer Therapy Increased, May Affect Treatment Adherence

Women being treated for breast cancer with aromatase inhibitors may experience extremely low estrogen levels resulting in a wide variety of side effects that a typical postmenopausal woman without cancer may not experience.

Data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Conference showed that women assigned to take aromatase inhibitors had increases in side effects such as hot flashes, decreased appetite, fatigue, fever, breast sensitivity, etc.

"Aromastase inhibitors represent one of the most major advances in breast cancer treatment," said Lisa Gallicchio, Ph.D., an epidemiologist at The Prevention and Research Center at Mercy Medical Center, Baltimore. "Their incorporation into the breast cancer treatment armamentarium has led to impressive reductions in breast cancer recurrence and mortality rates.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon